By Shish KaBob Seger
As global COVID-19 cases surpass 12 million, scientists are looking to the biological functions of cannabinoids as another tool in the fight against coronavirus mortality. The active molecular compounds in cannabis exhibit properties that could be useful against the inflammatory effects brought on by Covid-19 infection. Last April, a group of Canadian scientists claimed to have found particular strains that can both prevent and treat the infection by exploiting the anti-inflammatory effects of cannabinoids such as CBD and CBN.
Find the entire story here
This is not the first time that science has found credible evidence of CBD reducing lung inflammation. In 2019, the European Journal of Pharmacology published a study claiming cannabis reduces airway inflammation and fibrosis in experimental allergic asthma. The study determined that “CBD treatment decreased the inflammatory and remodeling processes in the model of allergic asthma. The mechanisms of action appear to be mediated by CB1/CB2 signaling, but these receptors may act differently on lung inflammation and remodeling.”
The same study concluded CBD reduced pulmonary fibrosis – a condition common among Covid patients where lung tissue is scarred hence reducing a patient’s breathing abilities.
The study claimed THC is also a promising anti-inflammatory yet is not as well tolerated as non-psychotropic cannabinoids. The researchers later noted that this “suggests its feasibility to reduce SARS-CoV2 induced lung inflammation/ pathology and disease severity.”
To be clear, science has come to no final conclusions regarding the efficacy of cannabis as a coronavirus treatment. The ‘catch 22’ is that until federal limitations on the study of cannabis as medicine are lifted, America will continue to play catch up with the rest of the world.
From the editor: if you can grow you can juice your own cannabinoid rich nutrients for the full spectrum entourage effect!
